Considering that overactive SUMOylation pathway was observed in bladder tumor patient samples in recent studies[30] and our unbiased screening result, it is likely that the elevated protein level of SETD8 is the result of the overactive SUMOylation in BC, which further enhances MYC methylation and tumor growth. Here, KMT5A is linked to urinary bladder neoplasm.